These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7203016)
21. Vasodilator treatment of heart failure. Taylor SH Practitioner; 1981 Oct; 225(1360):1419-29. PubMed ID: 7329932 [No Abstract] [Full Text] [Related]
22. Recent advances in vasodilator therapy. Part I: physiologic correlations. Aranda JM; Linares E; Hernández-López E; Cintrón G; Song S Bol Asoc Med P R; 1981 Jan; 73(1):3-10. PubMed ID: 7020713 [No Abstract] [Full Text] [Related]
23. [Vasodilator agents in chronic heart failure: which is the best option?]. Corbalán R; Kunstmann S; Jalil J Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172 [TBL] [Abstract][Full Text] [Related]
24. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. Fragasso G; Palloshi A; Puccetti P; Silipigni C; Rossodivita A; Pala M; Calori G; Alfieri O; Margonato A J Am Coll Cardiol; 2006 Sep; 48(5):992-8. PubMed ID: 16949492 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. Dávila DF; Núñez TJ; Odreman R; de Dávila CA Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399 [TBL] [Abstract][Full Text] [Related]
26. [Vasodilators in cardiac insufficiency]. Bernardi LF; de Nononay NC Arq Bras Cardiol; 1980 Jan; 34(1):53-62. PubMed ID: 7406738 [No Abstract] [Full Text] [Related]
27. Vasodilators. A re-evaluation of their role in heart failure. Stevenson LW; Fonarow G Drugs; 1992 Jan; 43(1):15-36. PubMed ID: 1372857 [TBL] [Abstract][Full Text] [Related]
28. Metabolic approach to heart failure - evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis. Jackson G Int J Clin Pract; 2006 Aug; 60(8):891-2. PubMed ID: 16893429 [No Abstract] [Full Text] [Related]
29. Therapy for congestive heart failure in the late 20th century. Maxwell LP; Jain A W V Med J; 1993 Apr; 89(4):148-51. PubMed ID: 8098171 [TBL] [Abstract][Full Text] [Related]
30. Vasodilator therapy: its role in treatment of acute left ventricular failure and mitral regurgitation. Palank EA Mil Med; 1977 Jun; 142(6):472-4. PubMed ID: 407497 [No Abstract] [Full Text] [Related]
31. Metabolic approach in heart failure: rethinking how we translate from theory to clinical practice. Tang WH J Am Coll Cardiol; 2006 Sep; 48(5):999-1000. PubMed ID: 16949493 [No Abstract] [Full Text] [Related]
32. Reduction of myocardial ischemic injury and left ventricular dysfunction by vasodilator therapy. Carraway RD South Med J; 1979 Nov; 72(11):1436-44. PubMed ID: 388650 [No Abstract] [Full Text] [Related]
33. [Clinical and diagnostic indications for the use of nitrates in dynamic heart defects (decompensation, left ventricular dysfunction without decompensation, etc]. Branzi A G Ital Cardiol; 1996 Sep; 26(9):1079-84. PubMed ID: 9036049 [No Abstract] [Full Text] [Related]
34. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure]. Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987 [TBL] [Abstract][Full Text] [Related]